← Leaderboards
Mary E Taplin
Univ Of Massachusetts Med Sch Worcester
$1,700,815
Attributed
$1,700,815
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $492.6K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,700,815 · 2
By mechanism
P50$1,384,651 · 1
U10$316,164 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Elinor Karlsson$7,513,144
- Michelle Alice Kelliher$16,226,746
- Susan L Swain$26,012,075
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAcuteCancer PreventionAdjuvant TherapyAgonistAndrogen ReceptorAndrogensAntagonistAutomobile DrivingBiological MarkersBlood BanksBone Marrow TransplantationBrain NeoplasmsBreast NeoplasmsAdjuvant StudyCancer Registry /ResourceCancer Rehabilitation /CareCancer RiskCastrate Sensitive Prostate CancerCastrationCdk4 GeneCell CycleCell Growth RegulationAcceleration
Grant awards (6)
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition$448,227
P50 · FY2025 · CA · contact PI
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition$443,790
P50 · FY2024 · CA · contact PI
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition$492,634
P50 · FY2023 · CA · contact PI
CANCER AND LEUKEMIA GROUP B$106,578
U10 · FY2002 · CA
CANCER AND LEUKEMIA GROUP B$96,811
U10 · FY2001 · CA
CANCER AND LEUKEMIA GROUP B$112,775
U10 · FY2000 · CA